Amarin Confirms Effective Date for 1-For-20 ADS Ratio Change
Amarin (NASDAQ: AMRN) has announced a 1-for-20 ADS ratio change effective April 11, 2025. This strategic move will adjust the ratio from one ADS representing one ordinary share to one ADS representing twenty ordinary shares.
The primary objective is to increase the per-share market price of Amarin's ADSs to meet Nasdaq's minimum bid price requirement of $1.00 and maintain the company's listing on The Nasdaq Capital Market. The company notes that there is no guarantee that the post-change trading price will be exactly twenty times the pre-change price.
The ratio change will not affect Amarin's ordinary shares, and the ADSs will continue trading under the symbol 'AMRN' on The Nasdaq Capital Market.
Amarin (NASDAQ: AMRN) ha annunciato un cambiamento del rapporto ADS da 1 a 20, che entrerà in vigore l'11 aprile 2025. Questa mossa strategica modificherà il rapporto da un ADS che rappresenta un'azione ordinaria a un ADS che rappresenta venti azioni ordinarie.
L'obiettivo principale è aumentare il prezzo di mercato per azione degli ADS di Amarin per soddisfare il requisito di prezzo minimo di offerta del Nasdaq di $1,00 e mantenere la quotazione della società sul Nasdaq Capital Market. L'azienda osserva che non c'è alcuna garanzia che il prezzo di trading dopo il cambiamento sarà esattamente venti volte il prezzo precedente.
Il cambiamento del rapporto non influenzerà le azioni ordinarie di Amarin e gli ADS continueranno a essere scambiati con il simbolo 'AMRN' sul Nasdaq Capital Market.
Amarin (NASDAQ: AMRN) ha anunciado un cambio en la relación de ADS de 1 por 20, que entrará en vigor el 11 de abril de 2025. Este movimiento estratégico ajustará la relación de un ADS que representa una acción ordinaria a un ADS que representa veinte acciones ordinarias.
El objetivo principal es aumentar el precio de mercado por acción de los ADS de Amarin para cumplir con el requisito de precio mínimo de oferta de $1.00 del Nasdaq y mantener la cotización de la empresa en el Nasdaq Capital Market. La compañía señala que no hay garantía de que el precio de negociación posterior al cambio sea exactamente veinte veces el precio anterior.
El cambio en la relación no afectará las acciones ordinarias de Amarin, y los ADS seguirán cotizando bajo el símbolo 'AMRN' en el Nasdaq Capital Market.
아마린 (NASDAQ: AMRN)은 2025년 4월 11일부터 1대 20의 ADS 비율 변경을 발표했습니다. 이 전략적 조치는 하나의 ADS가 하나의 보통주를 대표하는 것에서 하나의 ADS가 20개의 보통주를 대표하는 것으로 비율을 조정합니다.
주요 목표는 아마린의 ADS의 주당 시장 가격을 높여 나스닥의 최소 입찰 가격 요건인 $1.00을 충족하고 회사의 나스닥 자본 시장 상장을 유지하는 것입니다. 회사는 변경 후 거래 가격이 정확히 변경 전 가격의 20배가 될 것이라는 보장은 없다고 언급합니다.
비율 변경은 아마린의 보통주에 영향을 미치지 않으며, ADS는 나스닥 자본 시장에서 'AMRN' 기호로 계속 거래됩니다.
Amarin (NASDAQ: AMRN) a annoncé un changement de ratio ADS de 1 pour 20, effectif le 11 avril 2025. Ce mouvement stratégique ajustera le ratio d'un ADS représentant une action ordinaire à un ADS représentant vingt actions ordinaires.
L'objectif principal est d'augmenter le prix du marché par action des ADS d'Amarin pour répondre à l'exigence de prix d'offre minimum de $1,00 du Nasdaq et de maintenir la cotation de l'entreprise sur le Nasdaq Capital Market. L'entreprise souligne qu'il n'y a aucune garantie que le prix de négociation après le changement sera exactement vingt fois le prix avant le changement.
Le changement de ratio n'affectera pas les actions ordinaires d'Amarin, et les ADS continueront à être échangés sous le symbole 'AMRN' sur le Nasdaq Capital Market.
Amarin (NASDAQ: AMRN) hat eine Änderung des ADS-Verhältnisses von 1 zu 20 bekannt gegeben, die am 11. April 2025 in Kraft tritt. Dieser strategische Schritt wird das Verhältnis von einem ADS, das eine Stammaktie repräsentiert, auf ein ADS, das zwanzig Stammaktien repräsentiert, anpassen.
Das Hauptziel ist es, den Marktpreis pro Aktie der ADS von Amarin zu erhöhen, um die Mindestgebotsanforderung von $1,00 des Nasdaq zu erfüllen und die Listung des Unternehmens am Nasdaq Capital Market aufrechtzuerhalten. Das Unternehmen weist darauf hin, dass es keine Garantie dafür gibt, dass der Handelspreis nach der Änderung genau zwanzigmal so hoch sein wird wie der Preis vor der Änderung.
Die Änderung des Verhältnisses wird die Stammaktien von Amarin nicht beeinflussen, und die ADS werden weiterhin unter dem Symbol 'AMRN' am Nasdaq Capital Market gehandelt.
- Action taken to maintain Nasdaq listing status
- Company at risk of delisting due to share price falling below $1.00
- No guarantee that post-ratio change price will maintain desired levels
- Indicates significant decline in share value necessitating ratio adjustment
Action Taken to Maintain Company’s Nasdaq Listing
DUBLIN and BRIDGEWATER, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), today confirmed that April 11, 2025 will be the effective date for the Company’s previously announced Ratio Change on its American Depositary Shares (“ADS”) -- an action in which the Company will effect a ratio change from one (1) ADS representing one (1) ordinary share to a new ratio of one (1) ADS representing twenty (20) ordinary shares (the "Ratio Change").
The objective of this action is to increase the per share market price of the Company’s ADSs to comply with Nasdaq’s
The ordinary shares of Amarin Corporation (the “Company”) will not be affected by this Ratio Change. The ADSs will continue to trade on The Nasdaq Capital Market under the symbol “AMRN”.
Additional questions and answers regarding the Ratio Change can be found under the Investor Relations section of Amarin’s corporate web site here: https://cms.amarincorp.com/sites/default/files/2025-03/e6713d4c-9083-4623-a9e9-6b13d8a4201b.pdf
About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world.
Forward-Looking Statements
This press release contains forward-looking statements which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that are based on the beliefs and assumptions and information currently available to Amarin. All statements other than statements of historical fact contained in this press release are forward-looking statements, including statements regarding Amarin’s planned Ratio Change and its potential impact on the ADS trading price and on liquidity of the ADS, as well as Amarin’s ability to regain compliance with Nasdaq’s minimum bid price requirement and other continued listing requirements. These forward-looking statements are not promises or guarantees and involve substantial risks and uncertainties. A further list and description of these risks, uncertainties and other risks associated with an investment in Amarin can be found in Amarin's filings with the U.S. Securities and Exchange Commission, including Amarin’s annual report on Form 10-K for the fiscal year ended 2024.
Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Amarin undertakes no obligation to update or revise the information contained in its forward-looking statements, whether as a result of new information, future events or circumstances or otherwise. Amarin’s forward-looking statements do not reflect the potential impact of significant transactions the company may enter into, such as mergers, acquisitions, dispositions, joint ventures or any material agreements that Amarin may enter into, amend or terminate.
Availability of Other Information
Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (www.amarincorp.com/investor-relations), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended or the Securities and Exchange Act of 1934, as amended.
Amarin Contact Information
Investor & Media Inquiries:
Mark Marmur
VP, Global Corporate Communications & Investor Relations
Amarin Corporation plc
PR@amarincorp.com
FAQ
When will Amarin's (AMRN) 1-for-20 ADS ratio change take effect?
Why is Amarin (AMRN) implementing an ADS ratio change?
How will the AMRN ADS ratio change affect existing shares?
Will Amarin's stock symbol change after the ADS ratio adjustment?
